Hosted on MSN1d
ViiV Healthcare shares results from trial of Dovato and three-drug therapy for HIV
UK-based pharmaceutical company ViiV Healthcare has reported results from a trial of Dovato, a two-drug regimen consisting of ...
Aidsmap6y
Lamivudine/zidovudine
Lamivudine and zidovudine are medications used to treat HIV. They are antiretroviral drugs combined in one tablet. The usual adult dose is one tablet taken twice a day along with another ...
Medscape1d
Dolutegravir: A New HIV Integrase Inhibitor for the Treatment of HIV Infection
3TC: Lamivudine; ABC: Abacavir; DRV: Darunavir; DTG: Dolutegravir; EFV: Efavirenz; FTC: Emtricitabine; rtv: Ritonavir; TDF: Tenofovir. ↓: Decrease; ↑: Increase ...
Verywell Health on MSN1y
Combination Antiretroviral Therapy (cART) for HIV
Medically reviewed by Lindsay Cook, PharmD The acronym cART stands for "combination antiretroviral therapy." It refers to the combinations of drugs that are used to keep HIV infections under control.
pharmaphorum5d
FDA approves Merck’s Delstrigo and Pifeltro for HIV treatment
Merck, known as MSD outside the United States and Canada announced that the Food and Drug Administration (FDA) has approved two new HIV-1 medicines: Delstrigo and Pifeltro. The FDA has approved ...
ViiV Healthcare Announces Data Demonstrating Dovato (DTG/3TC) Is Highly Effective in Treatment-Naïve People With Advanced HIV
ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today ...
Medscape4d
Precore Mutant Chronic Hepatitis B -- Approach to Management
Currently available agents include interferon-alfa, lamivudine, and adefovir dipivoxil. A 12-month or longer course of interferon-alfa treatment or re-treatment achieves sustained biochemical ...
Joplin Globe6d
ViiV Healthcare expands on real-world data supporting use of long-acting therapies in diverse patient populations at HIV Glasgow
ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, will share new data from its industry-leading HIV treatment and prevention portfolio ...
Late-Breaking Clinical Data and Real-World Evidence Presented at HIV Glasgow as Gilead Extends Leadership Efforts Toward Ending the Epidemic
Gilead Sciences, Inc. (Nasdaq: GILD) today announced the upcoming presentation of HIV research findings at the International ...
Aidsmap5y
What are the side-effects of post-exposure prophylaxis (PEP)?
After 37 years of pioneering health journalism, community engagement, and empowerment through information, we have now ceased operations. This website will be accessible until September 2025, with all ...